Method and system of producing a cartridge for performing nucleic acid amplification tests, and cartridge produced therewith

A nucleic acid contamination-free cartridge system addresses sterility testing challenges by integrating all components and reagents in a cleanroom, ensuring accurate and reliable detection of microbial nucleic acids, reducing manual handling and enhancing test reliability.

WO2026074099A1 Publication Date: 2026-04-09SARTORIUS LAB INSTR GMBH & CO KG
8 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2025/078374
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-02
Filing Date
2025-10-02
Publication Date
2026-04-09

AI Technical Summary

Technical Problem

Current sterility testing methods for biological samples face challenges such as nucleic acid contamination, manual handling risks, and inadequate sample processing, leading to false positives and negatives, particularly in complex samples with low microbial counts or uneven contamination.

Method used

A nucleic acid contamination-free cartridge system is produced in a cleanroom environment, integrating all components and reagents to minimize human intervention, ensuring thorough lysis, homogenization, and accurate detection of microbial nucleic acids without interference from host DNA, using microfluidic channels and controllable valves for automated processing.

Benefits of technology

The system significantly reduces contamination risks, enhances accuracy and reliability of sterility testing, and improves patient safety by providing consistent and reproducible results, even in complex biological samples.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a cartridge for performing a nucleic acid amplification test of sterility on a sample, wherein the cartridge and all components are nucleic acid contamination-free. The cartridge is suitable for processing biological samples, whereas the nucleic acid sterility test detects all clinically relevant bacterial and / or fungal species. Further, the invention relates to a use of said cartridge for performing a nucleic acid amplification test and for detecting at least one fungal and / or at least one bacterial contamination. The invention also relates to a method of producing said cartridge in a nucleic-acid free environment and optionally with DNA-depleted and / or disinfected components. Further, the invention relates to a kit or a kit of parts comprising at least one nucleic acid contamination-free nucleic acid amplification reagent. The invention also relates to a device comprising said cartridge.
Need to check novelty before this filing date? Find Prior Art